Literature DB >> 1897908

Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system.

G Stoll1, B Schmidt, S Jander, K V Toyka, H P Hartung.   

Abstract

In this study, the terminal complement complex C5b-9 (TCC) was localized by immunocytochemistry at different clinical stages of experimental autoimmune neuritis. Deposits of TCC were found on the surface of Schwann cells and their myelin sheaths, and to some extent in the extracellular space at predilective sites of impending demyelination before onset of clinical signs and for a short period thereafter. Additionally, TCC was deposited on the surface of W3/13 positive leukocytes. No TCC immunoreactivity was seen in the distal stump of transected sciatic nerves 1 to 15 days after axotomy. The early and transient deposition of TCC on Schwann cells and myelin sheaths in experimental autoimmune neuritis before overt demyelination suggests that complement activation plays a pathogenic role in the initiation of immune-mediated myelin damage. The lack of TCC immunoreactivity after nerve transection excludes a nonspecific activation process. The signals involved in local TCC formation in demyelinating peripheral nervous system disorders have yet to be explored.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1897908     DOI: 10.1002/ana.410300205

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

1.  CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy.

Authors:  P M Abraham; S H Quan; D Dukala; B Soliven
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 2.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

3.  A role for complement in phagocytosis of myelin.

Authors:  B A DeJong; M E Smith
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

Review 4.  Molecules involved in the crosstalk between immune- and peripheral nerve Schwann cells.

Authors:  Nevena Tzekova; André Heinen; Patrick Küry
Journal:  J Clin Immunol       Date:  2014-04-17       Impact factor: 8.317

5.  Genetic regulation of microglia activation, complement expression, and neurodegeneration in a rat model of traumatic brain injury.

Authors:  Bo-Michael Bellander; Olle Lidman; Marcus Ohlsson; Britt Meijer; Fredrik Piehl; Mikael Svensson
Journal:  Exp Brain Res       Date:  2010-07-03       Impact factor: 1.972

6.  Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.

Authors:  Jérôme J Devaux
Journal:  Am J Pathol       Date:  2012-08-10       Impact factor: 4.307

7.  The membrane attack complex of complement mediates peripheral nervous system demyelination in vitro.

Authors:  W Brück; Y Brück; U Diederich; S J Piddlesden
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 8.  Guillain-Barré syndrome: clinical and immunological aspects.

Authors:  A M Rostami
Journal:  Springer Semin Immunopathol       Date:  1995

9.  Immunological mechanisms of demyelination.

Authors:  R A Hughes
Journal:  J R Soc Med       Date:  1992-01       Impact factor: 18.000

Review 10.  The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System.

Authors:  Kathleen M Hagen; Shalina S Ousman
Journal:  Front Aging Neurosci       Date:  2021-01-13       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.